Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Trillium Therapeutics Inc. V.SSS

Sector: Healthcare | Sub-Sector: Biotechnology
Primary Symbol: T.TR
Alternate Symbol(s):  SCTPD | SCTPF

Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immunoregulatory pathways that tumor cells exploit to evade the host immune system.

Latest Trillium Therapeutics Inc. News

1 2 3 4 5 Next

Stem Cell Therapeutics Provides Corporate Update

Marketwired   January 13, 2014
1 2 3 4 5 Next